Massimo Piracci completed his MBBS from Roma Tor Vergata, Italy in 1992 and subsequently received his MD in Orthopedic and Traumatology from the same University in 1999. He was trained in Orthopedic Surgery in Roma Saint Eugenio Hospital and in Latina Santa Maria Goretti Hospital. From 2003 was HOD in Orthopedic and Traumatology Department in Roma Clinic Annunziatella where he did more than 10.000 surgery. He was also Football Referee for FIGC for 15 years and also external orthopedic consultant for different football team. From 2014 in UAE. He uses the most advanced technologies and biological implant (PRP, Stamina cells, Ozone Therapy) and mini invasive surgery of hip head. He treats the most of orthopedic pathology for children and adults, the most of minor and major trauma, and sport injury with advanced mini invasive technique.

Dr. Mamoun Magzoub Mohamed Osman is an Associate Professor at the Faculty of Medicine, University of Kassala, Sudan. He has extensive experience in Microbiology and Parasitology and is fluent in both Arabic and English.

Dr. Amin Ullah Currently serving as an Assistant Professor at Allied Health Sciences, Iqra national university Peshawar, Pakistan, since February 2022. He has around 5 years of teaching and research experience. Dr. Amin specialty on profiling of circulatory microRNAs in hepatitis, liver disorders, COVID-19, cytomegalovirus, HIV, and other infectious diseases from both clinical epidemiological and molecular biology perspectives. In addition, I am conducting in vitro and in vivo/pre-clinical studies to evaluate the therapeutic potential of green-synthesized nanoparticles and drug-loaded nanoparticles against various cancer cell lines and rat models. He has supervised 45 M.Phil. research students and are mentoring Ph.D. candidates. He has more than 60+ publications of International and National in a well reputed journal with 300+ impact factor. His scientific activities are highly interdisciplinary, ranging from biotechnology and microbiology, diagnostic tools and computational biology. In addition, he has authored over 13 book chapters with renowned publishers, including Elsevier, Springer, and Taylor & Francis. Dr. Amin is currently serving as Chief Editor for two books under review. He also holds five international patents (Germany, UK). Beyond his research, he has contributed significantly to the scientific community by peer-reviewing manuscripts for more than 10 prestigious journals published by MDPI, Elsevier, Springer, and Wiley. In recognition of his academic excellence, Dr. Amin was awarded a fellowship under the HEC IRSIP program at the University of Cologne, Germany, in 2019.

Dr. Madhumita P. Ghosh is an Associate Professor at the Amity Institute of Biotechnology, Amity University, Noida. She earned her Ph.D. in Biotechnology from Jadavpur University, Kolkata in 2001. She conducted her postdoctoral research at the National Eye Institute (NIH, Bethesda, USA) under the mentorship of Dr. Samuel Zigler Jr., focusing on ocular disease mechanisms and cataractogenesis models.

She later worked at the National Brain Research Center (NBRC), New Delhi, where she investigated retinal degeneration models in mice. Since joining Amity University in 2008, Dr. Ghosh has progressed from Senior Lecturer to Associate Professor, contributing extensively to teaching and research in Animal Biotechnology and Immunology.

Her research primarily explores neuroprotection and retinal degeneration, focusing on antioxidant therapies, neuroprotective nanoformulations, and retinal precursor stem cell therapy. She has successfully led multiple DBT, DST-SERB, and ICMR-funded projects, and mentored several Ph.D. students.

Dr. Ghosh has published widely in reputed journals such as Experimental Eye Research, Nature Scientific Reports, Biomedicine & Pharmacotherapy, Molecular Vision, Toxicology Letters, ACS Applied Biomaterials, and Journal of Biomolecular Structure and Dynamics. Her work has made significant contributions to understanding oxidative stress, excitotoxicity, and neuroprotective drug delivery for ocular diseases.

Dr. Sarah Sarwar is an accomplished biochemist and molecular biologist currently serving as a Lecturer in Biochemistry at Shaheed Benazir Bhutto Women University, Peshawar. She possesses more than 15 years of academic and research experience in the fields of molecular biotechnology, biochemistry, and bioinformatics.
She earned her Ph.D. in Molecular Biotechnology from Abdul Wali Khan University Mardan, focusing on the comprehensive investigation of the leishmanicidal and pharmacological potential of Thiadiazine Thione derivatives through in-silico, in-vitro, and in-vivo approaches.
Her expertise encompasses molecular docking, nanobiotechnology, enzymology, drug discovery, plant and microbial cell culture, and bioremediation.
Dr. Sarwar has also contributed significantly to capacity building, organizing hands-on workshops, scientific seminars, and international conferences to promote research excellence and innovation in life sciences.